Moorestown, NJ — IonField Systems, the pioneer in plasma cleaning technology for life science applications, is pleased to announce the award of a Phase II Small Business Innovation Research (SBIR) grant totaling $1,000,000 for the development of an automated system to clean microplates with cold plasma technology. This project has been funded in whole or […]

New York, NY — Spring Mountain Capital, LP, a New York-based investment management firm, announced today that its private equity group structured and led a growth equity investment in IsoPlexis Corporation. IsoPlexis has developed a break-through single cell immunoassay and related software that provides in-depth understanding of immune and cancer cells. The Company’s advanced cell […]

Boston, MA –– Andrew Alliance announced today that the Company will be opening up a Boston office in Copley Square. The Company also announced the closing of a series B financing round from Omega Funds, a leading global healthcare fund specializing in late stage life science investments. The Omega investment will enable Andrew Alliance to […]

BUFFALO, N.Y. — Rand Capital Corporation (“Rand”) (Nasdaq:RAND) announced June 30, 2014 net asset value of $28.4 million, or $4.43 per share, representing a $.08 increase per share from March 31, 2014, and a $.50 per share increase from June 30, 2013. Portfolio activity during the second quarter of 2014 included: Empire Genomics, LLC (Buffalo, […]

MOUNTAIN VIEW, CA –– 23andMe, the leading personal genetics company, has received from the National Institutes of Health (NIH) a grant totaling $1,367,504 for a two-year project to support the further development of 23andMe’s web-based database and research engine for genetic discovery. Specifically, the grant supports four areas of development: •Refinement of web-based surveys to […]

BOULDER, CO — InDevR, a Boulder-based life science company, announced today that it has received an SBIR Phase II grant from the National Institute of Allergy and Infectious Diseases (NIAID) (R44AI102318) to expand application of its new vaccine potency assay to pandemic influenza vaccines. The award is approximately $1 M per year over three years. […]

ALEXANDRIA, VA -– Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of an $8 million senior secured term loan agreement with Natrix Separations, Inc. (“Natrix”). Proceeds of the loan will be used for working capital. “Oxford is pleased to provide […]

ANN ARBOR, Mich.– Advanced Photonix® (NYSE MKT: API) announced that it has received over $400,000 in orders from our value added resellers for multiple T-Gauge® online terahertz (THz) sensor systems in three different market segments; extruded plastics, carpet, and paper. The company expects these initial design wins will lead to multiple system sales in each […]

WARREN, N.J.– Roka Bioscience, Inc., a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $12.00 per share, before underwriting discounts. All of the common stock is […]

NEWARK, Calif. — StemCells, Inc. (Nasdaq:STEM), today announced its intent to offer and sell 11,299,435 shares of common stock and short term warrants for the purchase of up to 9,604,520 additional shares of common stock to two well recognized institutional biotechnology investors, subject to market and other conditions, for gross proceeds of $20 million, before […]